Cargando…
Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
BACKGROUND: Obesity has been associated with hepatic overexpression of the renin-angiotensin system (RAS). AIM: To evaluate the action of two angiotensin II (ANGII) receptor blockers (losartan or telmisartan) on the modulation of local hepatic RAS and the resulting metabolic effects in a diet-induce...
Autores principales: | Graus-Nunes, Francielle, Santos, Felipe de Oliveira, Marinho, Thatiany de Souza, Miranda, Carolline Santos, Barbosa-da-Silva, Sandra, Souza-Mello, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504859/ https://www.ncbi.nlm.nih.gov/pubmed/31114640 http://dx.doi.org/10.4254/wjh.v11.i4.359 |
Ejemplares similares
-
Telmisartan, when compared to losartan, shows additional beneficial effects to pancreatic islet structure and function in diet-induced obese mice
por: Graus-Nunes, Francielle, et al.
Publicado: (2015) -
Counter-regulatory renin–angiotensin system in cardiovascular disease
por: Paz Ocaranza, Maria, et al.
Publicado: (2019) -
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013) -
Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands
por: Cano, Isadora Prado, et al.
Publicado: (2019) -
Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)